Atrial fibrillation (AF), the most common chronic cardiac arrhythmia in clinical practice, is very challenging to treat once ...

James Marchant is a postdoctoral researcher in Alexandre Colas’s group at Sanford Burnham Prebys. In this Postdoc Portrait, he shares his work on developing a gene therapy for heart failure, why his ...

Atrial fibrillation (AF), the most common chronic cardiac arrhythmia in clinical practice, is very challenging to treat once ...

Study shows that cardiac spheroids, derived from human induced pluripotent stem cells, can be easily transported and injected into damaged areas of the heart to promote its regeneration and recovery ...

UC labs are developing new treatments that don’t just prevent damage from getting worse, but — for the first time in medical ...

Skeletal muscle and cardiovascular diseases continue to pose significant challenges to public health, affecting a wide range ...

Anatomically, cardiac rupture occurs at the intersection between injured and healthy cardiac tissue. This region is referred to as the borderzone. The conventional view is that increased mechanical ...

Khaberni - American researchers have discovered a new cellular mechanism that explains how an infection with the 'Influenza A' virus can cause heart damage. The study, which was prepared by a team of ...

Researchers at Mount Sinai have identified a cellular mechanism that links influenza A virus infection to heart damage and increased cardiovascular risk, while also demonstrating a novel modified ...